✦ LIBER ✦

1207 Results of study PX-171–007 a phase 1b/2 study of carfilzomib, a selective proteasome inhibitor, in patients with selected advanced metastatic solid tumors

✍ Scribed by M. Gordon; J. Infante; K.P. Papadopoulos; P. Lee; E. Sausville; D. Mendelson; A.F. Wong; M. Vallone; P.J. Rosen; H. Burris

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

385 POSTER A phase I safety, pharmacokin

✍ K.P. Papadopoulos; J.R. Infante; A.F. Wong; L.A. Kunkel; A. Patnaik; M. Goldston 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A phase I/II study of carfilzomib 2–10-m

✍ Papadopoulos, Kyriakos P.; Burris, Howard A.; Gordon, Michael; Lee, Peter; Sausv 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 491 KB

Phase 1 study of MLN8054, a selective in

✍ E. Claire Dees; Jeffrey R. Infante; Roger B. Cohen; Bert H. O’Neil; Suzanne Jone 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 328 KB

Phase I study of barasertib (AZD1152), a

✍ Gary K. Schwartz,Richard D. Carvajal,Rachel Midgley… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 389 KB

396 A Phase I, Dose-finding Study of BI

✍ de Jonge, M.; Sahebjam, S.; Mathijssen, R.H.; Razak, A.; van der Biessen, D.; Pr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 79 KB

9236 Results of PX-171–003-A0, part 1 of

✍ Siegel, D.; Vij, R.; Stewart, K.; Somlo, G.; Jakubowiak, A.; Kukreti, V.; Bahlis 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB